Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET-SHUTTLE trial of rocatinlimab, an investigational T-cell rebalancing therapy, will be presented as a late breaking ...

Kura Oncology, Inc. ( NASDAQ: KURA) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:50 PM EDT ...

Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced promising preliminary results from their ASCEND study, focusing on a new ...

Jefferies analysts expect a regulatory filing for rocatinlimab later this year, with a product launch in 2026.

Thousand Oaks, California Wednesday, September 10, 2025, 10:00 Hrs [IST] ...

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab ...

Results from the Phase III ASCEND trial (NCT05882877) showed rocatinlimab maintained long-term efficacy with a favorable ...

Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...

Amgen (AMGN) and Kyowa Kirin announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an ...

Scientists have decoded the 3D structure of an ancient viral protein hidden in our DNA. The HERV-K Env protein, found on cancer and autoimmune cells, has a unique shape that could unlock new ...

The Lee County Board of Commissioners sent a letter to President Donald Trump about the potential impacts of tariffs on the completion deadline for Kyowa Kirin’s site development.

The name of Huawei’s chipset, which was designed by semiconductor design subsidiary HiSilicon, was found prominently displayed in screenshots shared online by Pura 80 users after a system update of ...